6.6% and 3.9% yields! 2 FTSE 100 stocks I’d snap up for juicy returns

On the hunt for consistent and growing dividends, our writer earmarks these two FTSE 100 stalwarts that could help her achieve that.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Young black colleagues high-fiving each other at work

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

sdf

Two rock-solid FTSE 100 stocks I believe can offer good returns for me and my holdings are GSK (LSE: GSK) and Taylor Wimpey (LSE: TW.).

Here’s why I’d love to buy some shares when I next have some cash to invest.

GSK

As one of the leading names in pharmaceuticals, GSK offers excellent defensive traits, in my view. This is due to the cutting-edge pharma it produces with medicines and treatments to help the world heal from various ailments.

Last month, a judge in Delaware voted in favour of over 70,000 lawsuits to go ahead against the company. This related to GSK’s Zantac drug and its potential links to causing cancer. Although GSK denies any evidence to suggest a risk of cancer, the chance of major fines and reputational damage is a risk I’ll keep an eye on.

From a bullish view, and given the defensive aspects mentioned, I think there’s a lot to like about the business.

To start with, the shares currently trade on a price-to-earnings ratio of 14. It’s also set to go lower, based on forecasts. However, I do understand that forecasts don’t always come to fruition.

Next, GSK shares offer a dividend yield of 3.9%, which is broadly in line with the FTSE 100 average. I can see this dividend growing in the future too, based on the firm’s reputation, experience, and future pipeline. It is worth mentioning that dividends are never guaranteed.

Overall, an established name in the market, an enticing valuation, passive income opportunity, and what looks like a solid R&D pipeline with over 90 products to come, help me make an investment decision today.

Taylor Wimpey

House builders haven’t had a great time of things in the past 12-18 months, due to economic volatility. Higher inflation, interest rates, and a cost-of-living crisis have hurt earnings and sentiment.

Inflation levels are now down, and rumours of a potential interest rate cut could spell good news. A potential housing boom could be on the horizon. However, economic issues are one of the biggest risks for Taylor Wimpey, and something that could dent earnings and returns. For example, higher costs could mean tighter margins and profit levels. I’ll keep an eye on this.

If a housing boom is coming, Taylor Wimpey is primed to benefit. At present, the shares look attractive to me.

Taylor is one of the largest developers in the UK. It possesses a wide presence, as well as plenty of experience and a solid track record. This could serve it well as there is a housing crisis in the UK. With demand outstripping supply, there is an opportunity for the firm to capitalise, and grow earnings and performance.

Finally, the fundamentals look good to me too. Taylor possesses a healthy balance sheet, which can help stave off economic turbulence, as well as support growth. Plus, the shares offer a dividend yield of 6.6% and trade on a P/E ratio of just 14.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Sumayya Mansoor has no position in any of the shares mentioned. The Motley Fool UK has recommended GSK. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Young Black man sat in front of laptop while wearing headphones
Investing Articles

3 reasons I’m avoiding Lloyds shares despite their huge dividends!

Lloyds shares offer some of the most reliable dividend yields on the FTSE 100. But our writer Royston Wild still…

Read more »

Number three written on white chat bubble on blue background
Investing Articles

Just released: the 3 best growth-focused stocks to consider buying in July [PREMIUM PICKS]

Our goal here is to highlight some of our past recommendations that we think are of particular interest today, due…

Read more »

Portrait of a boy with the map of the world painted on his face.
Investing Articles

Warren Buffett’s Berkshire Hathaway dumped this growth stock. Here’s why I won’t

Eyebrows were raised when Warren Buffett's company invested in this Latin American fintech disruptor a few years ago. But now…

Read more »

Fireworks display in the shape of willow at Newcastle, Co. Down , Northern Ireland at Halloween.
Investing Articles

£15k to spend? 3 UK shares, investment trusts and ETFs to consider for a £1,185 second income

By harnessing a range of different dividend stocks, I'm confident this mini portfolio might pay a large long-term second income.

Read more »

Portrait of elderly man wearing white denim shirt and glasses looking up with hand on chin. Thoughtful senior entrepreneur, studio shot against grey background.
Investing Articles

Is Tesla stock about to crash?

Tesla stock was on the slide today, shedding around $80bn in market value. What's going on with the electric vehicle…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing Articles

Should British investors consider buying Apple stock while it’s down 14% in 2025?

Apple stock has underperformed in 2025, falling more than 10%. Is this the buying opportunity UK investors have been waiting…

Read more »

Two business people sitting at cafe working on new project using laptop. Young businesswoman taking notes and businessman working on laptop computer.
US Stock

2 AI growth shares that I think are still undervalued

Jon Smith flags up two AI growth shares that aren't as overhyped as some peers, making them appealing for him…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing Articles

Where is the next Nvidia stock right now?

Nvidia stock has delivered jaw-dropping gains. Here are 10 growth shares that have the potential to also produce big returns…

Read more »